본문으로 건너뛰기
← 뒤로

Predicting gastric cancer survival using machine learning: A systematic review.

메타분석 1/5 보강
World journal of gastrointestinal oncology 📖 저널 OA 100% 2024: 14/14 OA 2025: 188/188 OA 2026: 44/44 OA 2024~2026 2025 Vol.17(5) p. 103804
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
[METHODS] A comprehensive search of PubMed and Web of Science in November 2024 identified 16 relevant studies published after 2019.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
These results highlight the potential of ML-based models to improve clinical practice by enabling personalized treatment planning and risk stratification. [CONCLUSION] Despite challenges concerning retrospective studies and a lack of interpretability, ML models show promise; prospective trials and multidimensional data integration are recommended for improving their clinical applicability.

Wang HN, An JH, Wang FQ, Hu WQ, Zong L

📝 환자 설명용 한 줄

[BACKGROUND] Gastric cancer (GC) has a poor prognosis, and the accurate prediction of patient survival remains a significant challenge in oncology.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Wang HN, An JH, et al. (2025). Predicting gastric cancer survival using machine learning: A systematic review.. World journal of gastrointestinal oncology, 17(5), 103804. https://doi.org/10.4251/wjgo.v17.i5.103804
MLA Wang HN, et al.. "Predicting gastric cancer survival using machine learning: A systematic review.." World journal of gastrointestinal oncology, vol. 17, no. 5, 2025, pp. 103804.
PMID 40487963 ↗

Abstract

[BACKGROUND] Gastric cancer (GC) has a poor prognosis, and the accurate prediction of patient survival remains a significant challenge in oncology. Machine learning (ML) has emerged as a promising tool for survival prediction, though concerns regarding model interpretability, reliance on retrospective data, and variability in performance persist.

[AIM] To evaluate ML applications in predicting GC survival and to highlight key limitations in current methods.

[METHODS] A comprehensive search of PubMed and Web of Science in November 2024 identified 16 relevant studies published after 2019. The most frequently used ML models were deep learning (37.5%), random forests (37.5%), support vector machines (31.25%), and ensemble methods (18.75%). The dataset sizes varied from 134 to 14177 patients, with nine studies incorporating external validation.

[RESULTS] The reported area under the curve values were 0.669-0.980 for overall survival, 0.920-0.960 for cancer-specific survival, and 0.710-0.856 for disease-free survival. These results highlight the potential of ML-based models to improve clinical practice by enabling personalized treatment planning and risk stratification.

[CONCLUSION] Despite challenges concerning retrospective studies and a lack of interpretability, ML models show promise; prospective trials and multidimensional data integration are recommended for improving their clinical applicability.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (1)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기